دورية أكاديمية

Treatment for Stable Coronary Artery Disease: A Network Meta-Analysis of Cost-Effectiveness Studies.

التفاصيل البيبلوغرافية
العنوان: Treatment for Stable Coronary Artery Disease: A Network Meta-Analysis of Cost-Effectiveness Studies.
المؤلفون: Caruba, Thibaut, Katsahian, Sandrine, Schramm, Catherine, Charles Nelson, Anaïs, Durieux, Pierre, Bégué, Dominique, Juillière, Yves, Dubourg, Olivier, Danchin, Nicolas, Sabatier, Brigitte
المصدر: PLoS ONE; Jun2014, Vol. 9 Issue 6, p1-13, 13p
مصطلحات موضوعية: CORONARY heart disease treatment, COST effectiveness, FOLLOW-up studies (Medicine), MYOCARDIAL infarction, COMPARATIVE studies, META-analysis
مستخلص: Introduction and Objectives: Numerous studies have assessed cost-effectiveness of different treatment modalities for stable angina. Direct comparisons, however, are uncommon. We therefore set out to compare the efficacy and mean cost per patient after 1 and 3 years of follow-up, of the following treatments as assessed in randomized controlled trials (RCT): medical therapy (MT), percutaneous coronary intervention (PCI) without stent (PTCA), with bare-metal stent (BMS), with drug-eluting stent (DES), and elective coronary artery bypass graft (CABG). Methods: RCT comparing at least two of the five treatments and reporting clinical and cost data were identified by a systematic search. Clinical end-points were mortality and myocardial infarction (MI). The costs described in the different trials were standardized and expressed in US $ 2008, based on purchasing power parity. A network meta-analysis was used to compare costs. Results: Fifteen RCT were selected. Mortality and MI rates were similar in the five treatment groups both for 1-year and 3-year follow-up. Weighted cost per patient however differed markedly for the five treatment modalities, at both one year and three years (P<0.0001). MT was the least expensive treatment modality: US $3069 and 13 864 after one and three years of follow-up, while CABG was the most costly: US $27 003 and 28 670 after one and three years. PCI, whether with plain balloon, BMS or DES came in between, but was closer to the costs of CABG. Conclusions: Appreciable savings in health expenditures can be achieved by using MT in the management of patients with stable angina. [ABSTRACT FROM AUTHOR]
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19326203
DOI:10.1371/journal.pone.0098371